Name: GYRE Debt Components
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

Gyre Therapeutics, Inc. (GYRE) Debt Components

2018-12-31: Convertible Notes Payable, CurrentUSD $0.00; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
2018-09-30: Convertible Notes Payable, CurrentUSD $0.00; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
2018-06-30: Convertible Notes Payable, CurrentUSD $0.00; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).
2018-02-20: Convertible Notes Payable, CurrentUSD $0.00; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m).

Gyre Therapeutics, Inc. Debt Components

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period end	Convertible Notes Payable, Current USD	Long-term Debt, Current Maturities USD	Long-term Debt, Excluding Current Maturities USD	Long-term Debt USD	Long-Term Debt, Maturity, Year One USD	Long-Term Debt, Maturity, Year Two USD	Long-Term Debt, Maturity, Year Three USD	Long-Term Debt, Maturity, Remainder of Fiscal Year USD	Notes Payable, Related Parties, Current USD
2018-12-31	$0.00	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	$0.00	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	$0.00	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-02-20	$0.00	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	$5.08M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	$5.49M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	$5.77M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	$12.65M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	$19.40M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	$29.67M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	$30.34M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	$30.94M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	$33.74M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	$34.77M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$1.46M
2014-12-31	(m)	(m)	(m)	$0.00	(m)	(m)	(m)	(m)	(m)
2014-09-30	(m)	$478.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	(m)	$699.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	(m)	$776.00K	$142.00K	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	(m)	$853.00K	$283.00K	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	(m)	(m)	(m)	$1.14M	$853.00K	$283.00K	(m)	(m)	(m)
2013-09-30	(m)	$873.00K	$478.00K	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	(m)	$866.00K	$699.00K	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	(m)	$858.00K	$918.00K	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	(m)	$851.00K	$1.14M	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	(m)	(m)	(m)	$1.99M	(m)	$853.00K	$283.00K	$851.00K	(m)
2012-09-30	(m)	$844.00K	$1.35M	(m)	(m)	(m)	(m)	(m)	(m)
2012-06-30	(m)	$870.00K	$1.56M	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	(m)	$896.00K	$1.78M	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	(m)	$1.24M	$1.99M	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	(m)	$1.59M	$2.19M	(m)	(m)	(m)	(m)	(m)	(m)
2011-06-30	(m)	$1.91M	$2.44M	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	(m)	$1.71M	$1.35M	(m)	(m)	(m)	(m)	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
GERON CORP (GERN)	United States	$0.803B	-12.14
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78